Wcm Investment Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Wcm Investment Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$83.14 - $145.99 $4.72 Million - $8.3 Million	-56,823 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$110.08 - $142.92 $874,915 - $1.14 Million	-7,948 Reduced 12.27%	56,823 $6.74 Million
Q4 2021 Jan 26, 2022	BUY	$99.73 - $148.48 $372,691 - $554,869	3,737 Added 6.12%	64,771 $8.93 Million
Q3 2021 Nov 02, 2021	SELL	$98.85 - $138.91 $2.09 Million - $2.94 Million	-21,179 Reduced 25.76%	61,034 $8.48 Million
Q2 2021 Aug 05, 2021	BUY	$65.78 - $105.02 $215,166 - $343,520	3,271 Added 4.14%	82,213 $7.98 Million
Q1 2021 May 13, 2021	SELL	$64.07 - $91.75 $109,944 - $157,443	-1,716 Reduced 2.13%	78,942 $5.4 Million
Q4 2020 Feb 23, 2021	BUY	$65.07 - $98.24 $5.25 Million - $7.92 Million	80,658 New	80,658 $6.91 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $4.27 Million - $6.45 Million	-65,669 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$59.04 - $77.95 $231,377 - $305,486	3,919 Added 6.35%	65,669 $4.27 Million
Q2 2020 Aug 18, 2020	BUY	$29.01 - $74.23 $64,837 - $165,904	2,235 Added 3.76%	61,750 $4.52 Million
Q1 2020 May 08, 2020	BUY	$27.51 - $57.29 $473,887 - $986,877	17,226 Added 40.73%	59,515 $2.03 Million
Q4 2019 Feb 07, 2020	BUY	$40.86 - $57.65 $1.08 Million - $1.53 Million	26,481 Added 167.52%	42,289 $2.3 Million
Q3 2019 Oct 25, 2019	BUY	$37.38 - $49.47 $261,286 - $345,795	6,990 Added 79.27%	15,808 $660,000
Q2 2019 Aug 06, 2019	SELL	$39.79 - $67.01 $5,252 - $8,845	-132 Reduced 1.47%	8,818 $386,000
Q1 2019 May 13, 2019	BUY	$34.52 - $53.29 $308,954 - $476,945	8,950 New	8,950 $461,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wcm Investment Management, LLC with notifications on news.